Yet Another Study Confirms Yaz Increases Risk of Blood Clots
Ennis & Ennis, P.A. explains the findings of another recent study revealing the significant risk of developing dangerous blood blots associated with birth control pills such as Yaz and Yasmin.
- Ennis & Ennis
11/09/2011 - The Canadian Medical Association Journal released a study of 330,000 Israeli women indicating that blood clots were more likely for those who were taking Yaz and Yasmin, which are birth control pills that contain the synthetic hormone drospirenone, reported attorney David Ennis.
In this study, 359 cases of deep vein thrombosis and 159 cases of pulmonary embolism occurred. The risk of blood clots was 65 percent higher among drospirenone users than among women taking second-generation contraceptives containing levonorgestrel and norgestrel, and 43 percent higher than women on third-generation pills containing desogestrel, gestodene and norgestimate.
The risk was highest in the first four months of use. Other risk factors included high cholesterol, high blood pressure, cancer, obesity and older age.
Venous thromboembolism (VTE) occurs when a blood clot forms in the veins of the legs or pelvis. Clots can break away and travel through the blood stream to the lungs, causing a pulmonary embolism, which can be deadly.
Jennifer Wu, MD from Lenox Hill Hospital in New York led the study and commented, “I would probably avoid the ones (birth control] that contain drospirenone just because of the risk of the blood clots in the lungs and the legs.”
This is the third study to be released within the past two weeks to confirm the increased dangerous risks associated with drospirenone-containing birth control pills like Yaz and Yasmin. On October 25, 2011 The British Medical Journal released a study confirming the same findings and on October 27, 2011 the U.S. Food and Drug Administration (FDA) released their independent study findings confirming the significant increased risk associated with drospirenone. FDA advisers are scheduled to meet December 8 to further review the safety of drospirenone-containing contraceptives.
Attorney David Ennis recommends that women who have taken drospirenone-containing birth control pills and experienced any of these symptoms should first immediately consult with their physician. Next, the patient should fill out a MedWatch Form at http://www.fda.gov. Lastly, patients should seek the opinion of an experienced lawyer to explore their legal rights.
Ennis & Ennis P.A. is offering free nationwide confidential consultations for patients who are taking or have taken drospirenone-containing medications and suffer these symptoms by calling toll free 1-800-856-6405 or by going to http://www.ennislaw.com and completing an online case evaluation form.
Ennis & Ennis, P.A. is a nationwide law firm with offices in Ft. Lauderdale, Miami and Washington D.C. Ennis & Ennis, P.A. concentrates its practice in mass torts and represents individuals against pharmaceutical companies worldwide, as well as medical device makers.
Ennis & Ennis, P.A. has been representing clients individually since 1986 and has recovered over $100 million in settlements for its clients.
Ennis & Ennis, P.A. is also investigating cases involving, Accutane, Actos, Avandia, Fosamax, Paxil, Zoloft, Prozac, Depuy Hip Recall, Zimmer Hip Recall, Depakote, Reglan, SJS/Dilantin, Yaz, Yasmin, Ocella Birth Control Pills and Transvaginal Mesh Devices.
Remember the law limits the time in which you can file a claim, so don't wait to explore your legal rights. Call today toll free 1-800-856-6405 or visit www.ennislaw.com.
Yaz / Yasmin / Ocella Lawsuit News Archive::
If you or a loved one have suffered serious yaz side effects, injury or death while using Yaz you may be entitled to compensation. Contact the yaz side effects lawyers of Ennis & Ennis, P.A. today for a free nationwide case evaluation. Our experienced Yaz attorneys can answer any questions you may have about Yaz side effects or a potential Yaz lawsuit. Fill out the case evaluation form on this page or call toll free: 1.800.856.6405.
Under no circumstances should you discontinue taking any medication, including Yaz or one the generic versions, without first consulting with your doctor.